Chief Minister A. Revanth Reddy at the World Economic Forum in Davos, Switzerland, unveiling Telangana’s transformative Life Sciences Policy 2026-30. Photo: Telangana Government Press Office

From Local Leadership to Global Stage: Revanth Reddy’s Strategic Davos Mission

Chief Minister A. Revanth Reddy’s presence at the World Economic Forum Annual Meeting 2026 represents a calculated strategic pivot for Telangana’s economic development trajectory. Departing from Rajiv Gandhi International Airport at 9:30 AM IST on January 19, following his participation in the culturally significant Medaram Jatara festival, Reddy leads a 22-member state delegation comprising industry experts, department secretaries, and business leaders.

Unlike previous state representations at Davos, this mission centers on the formal launch of the Telangana Next-Gen Life Sciences Policy 2026-2030 – a comprehensive framework developed over 14 months through collaboration with industry stakeholders, academic institutions, and global consulting firms. The policy represents Telangana’s blueprint for transitioning from being India’s ‘Vaccine Capital’ to becoming a global leader in next-generation therapeutics and sustainable pharmaceutical manufacturing.

Green Pharma City concept rendering: Integrated sustainable ecosystem combining manufacturing facilities, R&D centers, residential zones, and educational institutions. Image: Telangana State Industrial Infrastructure Corporation

Inside the Next-Gen Life Sciences Policy: Strategic Framework and Implementation Roadmap

Based on comprehensive analysis of the policy document and briefings with Telangana Industries Department officials, the framework represents a significant evolution from the state’s previous industrial strategies. The policy acknowledges Telangana’s substantial achievements – contributing 40% of India’s pharmaceutical production and housing 1,500+ life sciences companies – while establishing ambitious new directions:

Four Strategic Pillars

• Advanced Therapeutics Acceleration: Dedicated infrastructure and incentives for cell and gene therapies, mRNA platforms, and personalized medicine through Genome Valley expansion, including the new 1 Bio facility for single-use bioprocessing.
• Sustainable Manufacturing Mandate: First-in-India requirement for zero-liquid discharge systems across all new pharmaceutical facilities, supported by centralized effluent treatment infrastructure and renewable energy integration at Green Pharma City.
• AI & Digital Integration: Establishment of the Telangana AI Hub for Life Sciences, offering subsidized computing resources and talent development programs to reduce drug discovery timelines by 50% and manufacturing defects by 35%.
• Global Value Chain Integration: The Telangana Global Life Sciences initiative creates dedicated platforms for technology transfer partnerships with leading institutions and corporations, with special focus on attracting anchor tenants from Europe and North America.

The policy introduces unprecedented financial mechanisms, including a ₹5,000 crore Life Sciences Innovation Fund co-managed with private equity partners, R&D subsidies up to 25% of capital expenditure, and specialized training grants covering 70% of costs for industry-specific skill development.

Green Pharma City: Engineering India’s Largest Sustainable Life Sciences Ecosystem

At the heart of Telangana’s vision lies Green Pharma City – a meticulously designed 12,000-acre integrated ecosystem positioned 25 kilometers from Rajiv Gandhi International Airport. Unlike traditional industrial parks, this development represents a paradigm shift in pharmaceutical infrastructure planning.

Green Pharma City is an integrated work-live-learn-play ecosystem designed to attract global talent while creating opportunities for local communities. The development features specialized zones for small-molecule manufacturing, biologics production, medical devices, and R&D centers, all interconnected through smart mobility solutions and digital infrastructure.

The economic impact projections are substantial: ₹72,000 crore in direct investments, 320,000 direct jobs, and an additional 240,000 indirect employment opportunities across supporting sectors. For Hyderabad’s youth, this translates to unprecedented career pathways beyond traditional manufacturing roles – in AI engineering, bioprocess technology, regulatory science, and sustainable supply chain management.

Davos 2026 Strategic Meetings: Global Partnerships Forging Telangana’s Future

CM Reddy’s meticulously planned engagement schedule at Davos reflects Telangana’s strategic priorities. The state’s dedicated pavilion – one of only three state-level pavilions from India – will host a series of high-level interactions designed to convert policy vision into concrete investment commitments.

Most significant are the one-on-one meetings with industry leaders, including:

• Technology Integration: Sessions with Google Cloud Healthcare and Salesforce leadership on AI implementation frameworks for drug discovery and clinical trials.
• Manufacturing Excellence: Strategic discussions with Novartis, Unilever, and Eli Lilly executives on sustainable manufacturing standards and technology transfer protocols.
• Digital Infrastructure: Partnership frameworks with Cisco and Infosys for creating digital twins of manufacturing facilities and supply chain optimization.
• Logistics Corridors: Negotiations with DP World and Tata Logistics on establishing specialized pharma corridors connecting Green Pharma City to global markets.

Industry analysts monitoring these engagements suggest Telangana could secure investment commitments exceeding ₹15,000 crore during the Davos week alone, significantly accelerating the policy’s implementation timeline.

The Telangana Pavilion at WEF Davos 2026 featuring interactive displays of Green Pharma City, Genome Valley expansion, and AI integration initiatives. Photo: Telangana Government

Hyderabad’s Transformation: From Genome Valley to Global Life Sciences Capital

The policy’s impact extends beyond new infrastructure to fundamentally transforming Hyderabad’s existing life sciences ecosystem. Genome Valley, India’s first organized biotech cluster, receives a strategic upgrade through the 1 Bio initiative – a 150,000 square-foot specialized facility for biologics manufacturing using single-use technology.

1 Bio addresses a critical gap in India’s biopharmaceutical ecosystem. Until now, companies developing novel biologics had to go overseas for manufacturing. This facility will retain intellectual property within India while creating high-value jobs for scientists and researchers.

Complementing this physical infrastructure, the Telangana AI Hub for Life Sciences establishes a collaborative platform between IT companies, pharmaceutical firms, and academic institutions. Initial focus areas include predictive toxicology modeling, clinical trial optimization using real-world data, and supply chain resilience through machine learning – all critical capabilities that attracted CM Reddy’s meetings with technology leaders at Davos.

The economic implications extend beyond job creation. Analysis by the Hyderabad Chamber of Commerce and Industry projects that successful implementation could increase average compensation in life sciences roles by 35-45% over current levels, while reducing the industry’s environmental footprint by 60% through mandated sustainability standards.

Frequently Asked Questions: Telangana’s Life Sciences Vision

Editorial Standards Disclosure: This article adheres to GovtMitra’s strict EEAT (Experience, Expertise, Authoritativeness, Trustworthiness) guidelines. Content is researched by domain experts, verified against primary sources, and reviewed by subject matter specialists. Our corrections policy and editorial independence statement are available at govtmitra.com/editorial-policy. First published January 19, 2026. Last updated 2:30 PM IST.